Selective incorporation of deuterium into heteroarenes without directing groups has been a long-standing problem. Monohydrido-bridged ruthenium complex [{(η6-p-cymene)RuCl}2(μ-H-μ-Cl)] catalyzes the site-selective deuteration of C–H bonds in five-membered azaarenes. Notably, active drug substances were directly deuterated under this catalytic condition. Remarkably, the reaction requires a minimal catalyst loading (0.5–1 mol %) and D2O is employed as a direct deuterium source for the deuteration of imidazole, thiazole, and indole derivatives that exhibited good to excellent deuterium incorporation.
No takes yet. Share an insight, caveat, or question.
Sahoo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: